Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Eli Lilly Whomps Novo Nordisk
Eli Lilly’s Zepbound Beats Novo Nordisk’s Wegovy in First Head-to-Head Study
People who took Zepbound lost 17 pounds more on average after 72 weeks of treatment than those who were given Novo Nordisk’s drug.
Eli Lilly's Zepbound Tops Novo Nordisk's Wegovy in Weight-Loss Trial
Eli Lilly's popular weight-loss drug Zepbound outperformed Danish drugmaker Novo Nordisk's Wegovy in a clinical trial, according results of the study released Wednesday.
Eli Lilly's Zepbound beats Wegovy in head-to-head weight loss trial
Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy in a study.
3d
Exclusive: Novo Nordisk India execs urge early Wegovy launch as weight-loss rival looms
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular ...
1d
on MSN
Eli Lilly to Expand Facility to Meet Demand for Diabetes, Obesity Treatments
Eli
Lilly
said it would invest $3 billion to expand a recently ... a study that claimed that its Zepbound obesity drug is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Manslaughter charge dropped
US adds 227,000 jobs
Family awarded $310 million
Taking extended leave
Drops bid for third term
Federal fraud charges arrest
Biden considers pardons
‘One Life to Live’ star dies
Several prisons to be closed
Trump shows public support
Wild bird lays egg at 74
Promotes trade w/ Mexico
White Sox legend dies
Oven gloves recalled
Hit six months in space
Recalls 300K+ Ram trucks
Massive fire in Baltimore
'Patriot of the Year' award
Iran: Space launch successful
Ethics report release blocked
Pledges hit $100 billion
AI bias meter coming
Romanian election annulled
Judge rejects plea deal
Moon missions delayed
Sacks to lead AI, crypto
Syrian rebels advance
Messi wins MLS MVP award
Appeals court upholds ban
NBA returning to China
Scott tapped to lead CBP
Blackhawks fire coach
Joins X Games as CEO
Havana syndrome report
Feedback